Simultaneous muscle water T2 and fat fraction mapping using transverse relaxometry with stimulated echo compensation.
Benjamin Marty, Pierre-Yves Baudin, Harmen Reyngoudt...
https://pubmed.ncbi.nlm.nih.gov/26814454Actively Recruiting
Led by Beth Israel Deaconess Medical Center · Updated on 2026-04-03
150
Participants Needed
1
Research Sites
13 weeks
Total Duration
B
Beth Israel Deaconess Medical Center
Lead Sponsor
N
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor
Researchers are investigating a device called the mScan, which uses Electrical Impedance Myography (EIM) to measure muscle health in people with and without muscle diseases. The study aims to compare the mScan's measurements with those from magnetic resonance imaging (MRI), which is commonly used to track muscle conditions but has limitations like high cost and inconvenience. The goal is to develop a quicker, easier, and less expensive way to assess muscle health that could help monitor treatment effects in muscle disorders. The study involves using the mScan device, which applies a small, painless electrical current to muscles and records the muscle's response. This technology is being studied as a potential alternative to MRI because it is faster, more convenient, and does not require complex image analysis. Participants include healthy individuals and those with muscle diseases called myopathies. The study compares muscle measurements from the mScan with those from MRI over two years. Participants will undergo assessments using both the mScan device and MRI scans to collect data on muscle condition, including muscle size, fat content, swelling, and fiber organization. Researchers will apply machine learning to connect the mScan data with MRI findings to create predictive models of muscle pathology. The study may also involve DXA scans and excludes those with certain conditions that interfere with these tests. The total study duration is two years, focusing on developing algorithms to improve muscle disease assessment.
CONDITIONS
Muscle Health Measurements Using Electrical Impedance Myography
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 years
Participants undergo Electrical Impedance Myography (EIM) measurements to assess muscle health as a proxy for MRI.
Visits scheduled as needed during the study period
Duration - Up to 2 years
Participants are monitored over time to track changes in muscle pathology using EIM data.
Periodic visits for assessments during the study period
Total: 1 location
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Benjamin Marty, Pierre-Yves Baudin, Harmen Reyngoudt...
https://pubmed.ncbi.nlm.nih.gov/26814454Seward B Rutkove, Tom R Geisbush, Aleksandar Mijailovic...
https://pubmed.ncbi.nlm.nih.gov/24814059Craig M McDonald, Erik K Henricson, R Ted Abresch...
https://pubmed.ncbi.nlm.nih.gov/23674289Pushpa Narayanaswami, Michael Weiss, Duygu Selcen...
https://pubmed.ncbi.nlm.nih.gov/25313375Nathalie Goemans, Brenda Wong, Marleen Van den Hauwe...
https://pubmed.ncbi.nlm.nih.gov/32555695Raghav Govindarajan, Pushpa Narayanaswami
https://pubmed.ncbi.nlm.nih.gov/29665019Sarbesh R Pandeya, Janice A Nagy, Daniela Riveros...
https://pubmed.ncbi.nlm.nih.gov/33759456Kush Kapur, Janice A Nagy, Rebecca S Taylor...
https://pubmed.ncbi.nlm.nih.gov/30175407Seward B Rutkove, Jim S Wu, Craig Zaidman...
https://pubmed.ncbi.nlm.nih.gov/27825055Lindsay P Garmirian, Anne B Chin, Seward B Rutkove
https://pubmed.ncbi.nlm.nih.gov/19058193